1. Home
  2. FATE vs GHM Comparison

FATE vs GHM Comparison

Compare FATE & GHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATE
  • GHM
  • Stock Information
  • Founded
  • FATE 2007
  • GHM 1936
  • Country
  • FATE United States
  • GHM United States
  • Employees
  • FATE N/A
  • GHM N/A
  • Industry
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • GHM Industrial Machinery/Components
  • Sector
  • FATE Health Care
  • GHM Industrials
  • Exchange
  • FATE Nasdaq
  • GHM Nasdaq
  • Market Cap
  • FATE 406.5M
  • GHM 480.7M
  • IPO Year
  • FATE 2013
  • GHM N/A
  • Fundamental
  • Price
  • FATE $1.27
  • GHM $44.68
  • Analyst Decision
  • FATE Hold
  • GHM Buy
  • Analyst Count
  • FATE 10
  • GHM 1
  • Target Price
  • FATE $6.75
  • GHM $35.00
  • AVG Volume (30 Days)
  • FATE 3.2M
  • GHM 92.0K
  • Earning Date
  • FATE 02-24-2025
  • GHM 02-03-2025
  • Dividend Yield
  • FATE N/A
  • GHM N/A
  • EPS Growth
  • FATE N/A
  • GHM 172.71
  • EPS
  • FATE N/A
  • GHM 0.71
  • Revenue
  • FATE $13,447,000.00
  • GHM $196,402,000.00
  • Revenue This Year
  • FATE N/A
  • GHM $13.21
  • Revenue Next Year
  • FATE N/A
  • GHM $9.89
  • P/E Ratio
  • FATE N/A
  • GHM $62.82
  • Revenue Growth
  • FATE N/A
  • GHM 11.88
  • 52 Week Low
  • FATE $1.04
  • GHM $18.90
  • 52 Week High
  • FATE $8.83
  • GHM $49.28
  • Technical
  • Relative Strength Index (RSI)
  • FATE 31.94
  • GHM 55.32
  • Support Level
  • FATE $1.22
  • GHM $40.50
  • Resistance Level
  • FATE $1.36
  • GHM $49.28
  • Average True Range (ATR)
  • FATE 0.15
  • GHM 2.06
  • MACD
  • FATE -0.02
  • GHM -0.14
  • Stochastic Oscillator
  • FATE 24.21
  • GHM 47.61

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About GHM Graham Corporation

Graham Corporation designs and manufactures mission-critical fluid, power, heat transfer, and vacuum technologies for the defense, space, energy, and process industries. The company also services and sells spare parts for its equipment. It designs and manufactures custom-engineered vacuum, heat transfer, cryogenic pump and turbomachinery technologies.

Share on Social Networks: